GTCbio

Dr. Jeremy Caldwell, Executive Director of Molecular and Cell Biology at the Genomics Institute of the Novartis Research Foundation will give the Featured Presentation at GTCbio’s 4th Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Caldwell will discuss broad functional profiling of molecular libraries against biological space. - March 23, 2008

GTCbio just announced its holding the annual Modern Drug Discovery and Development Summit taking place on October 15-17, 2008 in San Diego, CA. Now in its fourth year, the summit will once again provide a landscape and in-depth industry analysis streaming through different therapeutic and target areas and examining the current advancements and where we’re headed in the coming years. - March 23, 2008

Massachusetts Senator Richard T. Moore to give Keynote Presentation at GTCbio’s 4th International Conference on Stem Cell Research & Therapeutics on April 17-18, 2008 in Boston, MA - March 08, 2008

2005’s new trend of Big Pharma acquisitions of small companies developing monoclonal antibodies has sparked a renewed interest for investors in the anti-infectives space. Four leading expert Venture Capitalists will meet to discuss the various investment opportunities in infectious diseases at... - January 26, 2008

Roderic Pettigrew, Director at the National Institute of Biomedical Imaging & Bioengineering, NIH will give the keynote presentation at GTCbio’s 3rd Imaging in Drug Development conference March 17-18, 2008 in San Diego, CA. Dr. Pettigrew will discuss the importance of imaging in 21st century... - January 26, 2008

Dr. Hisataka Kobayashi, Chief Scientist of Molecular Imaging at the National Cancer Institute will speak at GTCbio’s 3rd Imaging in Pre-clinical & Clinical Drug Development conference March 17-18, 2008 in San Diego, CA. Dr. Kobayashi will discuss environment sensitive "smart" imaging... - January 26, 2008

GTCbio announces the 4th International Stem Cell Research & Therapeutics on April 17-18, 2008 in Boston, MA – featuring a keynote presentation from the Rudolf Jaenisch, a Founding Member of Whitehead Institute, a pioneer of transgenic science, and a leader in the field of therapeutic cloning, also called nuclear transfer. - January 26, 2008

Dr. Christophe Labie, Group Leader of the Molecular Neurobiology Group at Sanofi-Aventis will give a presentation entitled “Stimulation of Brain Neurogenesis: A Way to Replace Neuron Loss in Diseased or Injured Brain” at GTCbio’s 4th Stem Cell Research & Therapeutics on April 17-18,... - January 24, 2008

James Chafouleas, Director of Global Licensing – Virology at Boehringer Ingelheim and Leigh Farrell, Vice President of Business Development at Biota will give a joint presentation entitled “Making the Right Deal: It’s Not Just About the Money” at GTCbio’s 5th Anti-Infectives... - January 09, 2008

Eicke Latz, Assistant Professor in Medicine of the Division of Infectious Diseases and Immunology at University of Massachusetts Medical School will give a presentation entitled “Mechanisms of Crystal Recognition by Inflammasomes” at GTCbio’s 6th Cytokines and Inflammation (January... - January 09, 2008

Susanta K. Sarkar, Director of the Molecular Imaging Center of Excellence at GlaxoSmithKline will speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego. Dr. Sarkar will present on molecular imaging approaches to in vivo pharmacokinetic and pharmacodynamic... - January 09, 2008

Mark Coflin, Global Executive Director of IDTI Alliance Mgmt at Novartis and Margery B. Fischbein, Vice President of Business Development & Strategic Planning at Human Genome Sciences will give a joint presentation at GTCbio’s 5th Anti-Infectives Partnering & Deal-Making Summit taking place... - January 09, 2008

Thomas Schall, President & CEO of ChemoCentryx will give a presentation entitled “Inhibition of CCR9 as a Therapeutic Approach: Beyond the Small Intestine” at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida.) CCR9 is a chemokine receptor known to... - January 09, 2008

Dimitry M. Danilenko, Senior Pathologist of the Department of Pathology at Genentech will give a presentation entitled “IL-22, a Th17 Cytokine, Plays an Important Role in Psoriasis as well as in Mucocutaneous Host Defense” at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008,... - January 09, 2008

Joseph Frank, Chief, Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology at NIH will speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego. Dr. Frank will present on using MRI to monitor cellular therapy. Magnetic labeling of cells provides... - January 09, 2008

Shelia Violette, Director of Discovery Immunology at Biogen-Idec will give a presentation entitled “The Alphavbeta6 Integrin: A Mediator of TGF-Beta Activation and Therapeutic Target in Fibrosis and Oncology” at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando,... - January 09, 2008

Jianhua Chao, Principal Scientist of Discovery Chemical Research at Schering-Plough will give a presentation entitled “Potent, Orally Active CXCR2-CXCR1 Antagonists as Anti-inflammatory Therapy” at GTCbio’s 6th Cytokines and Inflammation. (January 28-29, 2008, Orlando, Florida) Dr.... - January 07, 2008

Joost J. Oppenheim, Chief of the Laboratory of Molecular Immunoregulation at NCI, NIH, will be the honored keynote speaker at the 6th Cytokines and Inflammation conference to be held January 28-29, 2008 in Orlando, FL. Dr. Oppenheim has done many pioneering studies of cytokines including IL-1 and participated... - December 21, 2007

Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix. Dr. Copeland will present on mechanism-driven approaches to molecularly targeted cancer drug discovery. Oncology... - December 21, 2007

Presenters from GSK, Pfizer, Abbott, Schering-Plough, Bristol-Myers Squibb, GE, Siemens, NIH and more to speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego. Presenting organizations at the 3rd Imaging in Pre-clinical & Clinical Drug Development conference... - December 21, 2007

Thomas Waldmann, Chief of Metabolism & Head of Cytokine Immunology/ Immunotherapy at NCI to give keynote presentation at 2nd Immunodiagnostics & Immunomonitoring conference December 6-7, 2007 - November 22, 2007

Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008. - November 11, 2007

Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix. Dr. Copeland will present on mechanism-driven approaches to molecularly targeted cancer drug discovery. Oncology... - November 11, 2007

Gary Peltz, Head of Genetic/Genomics at Roche to give keynote presentation at PK/PD track at 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 in San Francisco. - October 26, 2007

Dr. Stephen K. Burley, CSO and SVP of Research at SGX Pharmaceuticals will give the Keynote presentation at GTCbio’s Drug Design & Lead Discovery conference – one of six tracks at the 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 in San Francisco. - October 19, 2007

Dr. David Kaslow, VP of Infectious Diseases and Vaccines at Merck will give the Keynote presentation at GTCbio’s Biological Therapeutics conference – one of six tracks at the 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 at the Hyatt Regency San Francisco Airport. - October 19, 2007

GTCbio announces it’s the 5th anniversary of its vaccine conference held annually in Washington D.C. - October 15, 2007

The 3rd World Summit on Metabolic Diseases explores the latest findings and treatments for Metabolic Diseases - October 15, 2007

COO of Chorus, Eli Lilly & Co. announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D). - October 13, 2007

GTCbio announces its flagship event – the 3rd Modern Drug Discovery and Development Summit (M3D) on Nov. 28-30, 2007 in San Francisco – featuring four plenary keynote speeches from top level execs at Pfizer, Eli Lilly, Wyeth as well as Nobel Laureate Ferid Murad at UT Houston. - October 11, 2007

SVP and Site Head of Pfizer La Jolla announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D). - October 10, 2007

Dr. Ferid Murad who received a Nobel Prize in Physiology and Medicine will be among the plenary keynote presenters at GTCbio’s 3rd Modern Drug Discovery and Development Summit on November 28-30 in San Francisco, CA. - July 28, 2007

Pfizer to Present on Safety Biomarkers, Regulatory Strategies, and Risk Management in Oncology IND Programs at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference (July 23-24, 2007, San Diego, CA) - June 23, 2007

Dr. Daniel Chelsky, Chief Scientific Officer at Caprion Pharmaceuticals will present on Secreted Proteins as Biomarkers: Catching Them at the Source at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference taking place on July 23-24, 2007 at the San Diego Marriott... - June 23, 2007

Dr. Steven M. Anderson, National Director of Research and Development at Laboratory Corporation of America will present on Development of Companion Diagnostics: Role of Clinical Reference Laboratories at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference taking... - June 23, 2007

Dr. Aaron B. Kantor, Executive Director of Cell and Molecular Biology, Biomarker Discovery Sciences at PPD, Inc. will present on Pharmacodynamic Biomarkers Identified with Broad-Based Phenotyping at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference taking place... - June 23, 2007

Biotech/Pharmaceutical conference (GTCbio's Rediscovering Biomarkers: Detection, Development and Validation conference) features Boehringer-Ingelheim at San Diego event. - May 12, 2007

Dr. G. Frank Liu, Director, Vaccine Clinical Biostatistics at Merck & Company in New Jersey will give a presentation entitled “Efficient Flexible Designs to Target Various Treatment Effect Size in an Interval” at Targeted Designs for Clinical Trials Conference on July 19 – 20, 2007... - May 12, 2007

Biotech/Pharmaceutical conference (GTCbio's Rediscovering Biomarkers: Detection, Development and Validation conference) features Roche Diagnostics at San Diego event. - May 10, 2007

GTCbio announces fellowship winners who receive monetary award to help in the advancement of scientific research. GTCbio also makes a donation to the Doctors around the World Charity. - April 19, 2007

Biotech/Pharmaceutical conference (GTCbio's Protein Kinases in Drug Discovery conference) features special panel discussion with industry leaders - April 14, 2007

Bioshield has been in place for 18 months. What progress has been made in the effort to protect Americans from potential chemical, biological, radiological or nuclear (CBRN) attacks? Experts will discuss this issue in a panel entitled, “The Progress of Bioshield.” - January 18, 2007

An upcoming conference on Epigenetic Cancer Therapy will bring scientists together to discuss research that targets epigenetic processes for cancer therapy. - November 07, 2006

An upcoming conference on Drug Delivery Technology will bring together scientists to discuss research aimed at creating safe and non-invasive treatments for cancer, diabetes, asthma, Alzheimer’s, cardiovascular disease and a host of other conditions. - November 06, 2006

The aim of this conference is to provide an in-depth look at various model systems and their potential to accelerate drug discovery and development. Topics to be covered are Model Organisms as Research & Development Tools, Clinical & Preclinical Developments, Transgenic Model Organisms, Target Validation, Toxicology & Efficacy and Therapeutic Strategies for Specific Diseases. - November 04, 2006

Bert Vogelstein to present on “Translational Implications of Colorectal Cancer Genetics” at GTCbio’s 3rd International Conference on Tumor Progression & Therapeutic Resistance. - August 29, 2006

Allen D, Roses, Senior Vice President of Pharmacogenetics for GlaxoSmithKline, will deliver a presentation entitled, “Translational Genetics - New Targets and Pharmacogenetic Differentiation of Medicines” on September 18, 2006. - August 12, 2006

Mahdi Fawzi of Wyeth Research, Allen D. Roses of GlaxoSmithKline, James Summers of Abbott Laboratories, Keith James of Pfizer and Lester Crawford, Former FDA Commissioner and Senior Counsel of Policy Directions, Inc are announced as Keynote Speakers for the 2nd Modern Drug Discovery & Development Summit (M3D). - August 04, 2006